$1.5M Commitment Advances Breakthrough Leukemia Research at CU Anschutz
New support from the Mike and Sofia Segal Foundation will expand innovative CD64 CAR T-cell therapy research and clinical trials for CMML patients. GIFT ANNOUNCEMENT June 9th, 2026 Colleagues, We are pleased to announce the establishment of the Mike and Sofia Segal Foundation CMML Research Fund, supported by a $1.5 million commitment from the Mike…